MultiCell Technologies, Inc.
OTC: MCET0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- W. Gerald Newmin
- Employees
- 2
- Headquarters
- Woonsocket, United States
- IPO year
- 2000
- Market cap
- $50.0K
- Website
- https://www.multicelltech.com
Loading MCET…
Loading profile data…Frequently asked questions about MCET
What does MultiCell Technologies, Inc. (MCET) do?
MultiCell Technologies, Inc. (MCET) operates as a biopharmaceutical firm, primarily focused on the creation of innovative therapeutic agents and research tools. Their efforts are directed towards addressing a range of medical challenges, including neurological conditions, liver ailments, various types of cancer, and applications within intervent...
Where does MCET trade?
MultiCell Technologies, Inc. (MCET) trades on the Other OTC.
What sector is MCET in?
MultiCell Technologies, Inc. (MCET) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of MultiCell Technologies, Inc.?
W. Gerald Newmin is the chief executive officer of MultiCell Technologies, Inc. (MCET).
Where is MultiCell Technologies, Inc. headquartered?
MultiCell Technologies, Inc. is headquartered in United States.
Does MCET pay a dividend?
MultiCell Technologies, Inc. (MCET) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did MCET go public?
MultiCell Technologies, Inc. (MCET) completed its initial public offering in 2000.